These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25639820)

  • 1. First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation.
    Thompson O; Otigbah C; Nnochiri A; Sumithran E; Spencer K
    BJOG; 2015 Sep; 122(10):1370-6. PubMed ID: 25639820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between first trimester aneuploidy screening test serum analytes and placenta accreta.
    Büke B; Akkaya H; Demir S; Sağol S; Şimşek D; Başol G; Barutçuoğlu B
    J Matern Fetal Neonatal Med; 2018 Jan; 31(1):59-62. PubMed ID: 28027672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study.
    Berezowsky A; Pardo J; Ben-Zion M; Wiznitzer A; Aviram A
    Fetal Diagn Ther; 2019; 46(3):187-192. PubMed ID: 30726846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First trimester serum PAPP-A is associated with placenta accreta: a retrospective study.
    Wang F; Chen S; Wang J; Wang Y; Ruan F; Shu H; Zhu L; Man D
    Arch Gynecol Obstet; 2021 Mar; 303(3):645-652. PubMed ID: 33515274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated first trimester PAPP--a is associated with increased risk of placenta accreta.
    Desai N; Krantz D; Roman A; Fleischer A; Boulis S; Rochelson B
    Prenat Diagn; 2014 Feb; 34(2):159-62. PubMed ID: 24226752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of β-human-derived chorionic gonadotrophic hormone (βhCG) and pregnancy-associated plasma protein A (PAPP-A) levels as predictive factors of preeclampsia in the first trimester among Iranian women: a cohort study.
    Honarjoo M; Kohan S; Zarean E; Tarrahi MJ
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):464. PubMed ID: 31801467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First- and second-trimester maternal serum markers of pre-eclampsia in twin pregnancy.
    Svirsky R; Levinsohn-Tavor O; Feldman N; Klog E; Cuckle H; Maymon R
    Ultrasound Obstet Gynecol; 2016 May; 47(5):560-4. PubMed ID: 25865365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester markers of aneuploidy in women positive for HIV.
    Savvidou MD; Samuel I; Syngelaki A; Poulton M; Nicolaides KH
    BJOG; 2011 Jun; 118(7):844-8. PubMed ID: 21062401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus.
    Savvidou MD; Syngelaki A; Muhaisen M; Emelyanenko E; Nicolaides KH
    BJOG; 2012 Mar; 119(4):410-6. PubMed ID: 22324916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies.
    Giorgetti C; Vanden Meerschaut F; De Roo C; Saunier O; Quarello E; Hairion D; Penaranda G; Chabert-Orsini V; De Sutter P
    Hum Reprod; 2013 Oct; 28(10):2636-42. PubMed ID: 23887070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.
    Spencer K; Cowans NJ; Molina F; Kagan KO; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of type 1 diabetes and glycemic control on fetal aneuploidy biochemical markers.
    Madsen HN; Ekelund CK; Tørring N; Ovesen PG; Friis-Hansen L; Ringholm L; Petersen OB
    Acta Obstet Gynecol Scand; 2012 Jan; 91(1):57-61. PubMed ID: 21671890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A first trimester prediction model for gestational diabetes utilizing aneuploidy and pre-eclampsia screening markers.
    Sweeting AN; Wong J; Appelblom H; Ross GP; Kouru H; Williams PF; Sairanen M; Hyett JA
    J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2122-2130. PubMed ID: 28562122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of the routine first-trimester antenatal screening program for aneuploidy in the assessment of the risk of placenta accreta spectrum disorders.
    Penzhoyan GA; Makukhina TB
    J Perinat Med; 2019 Dec; 48(1):21-26. PubMed ID: 31730533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
    Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
    Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between maternal serum free beta-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels in first-trimester twin and singleton pregnancies.
    Mashiach R; Orr-Urtreger A; Yaron Y
    Fetal Diagn Ther; 2004; 19(2):174-7. PubMed ID: 14764965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of preimplantation genetic testing for aneuploidies (PGT-A) on first trimester biochemical markers - PAPP-A (placenta-associated plasma protein) and free β-hCG (human chorionic gonadotropin).
    Markova D; Kagan O; Hoopmann M; Abele H; Coughlan C; Abecia E; Fatemi HM; Lawrenz B
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6097-6103. PubMed ID: 33823722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K; Bindra R; Cacho AM; Nicolaides KH
    Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A re-evaluation of the influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy.
    Spencer K; Cowans NJ; Spencer CE; Achillea N
    Prenat Diagn; 2010 Oct; 30(10):937-40. PubMed ID: 20687123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.